DCVC Bio GP, LLC current holdings: USA Stocks
DCVC Bio GP, LLC reported $0.00 billion in share positions in stocks (listed in the US), 1 positions, in its Form 13F for the quarter ended 2022-09-30; the largest are ABCL.
- ABCL: Country of operation —; Class COM; Shares 0; Value $0.
Form 13F-HR as filed (SEC CIK 1735070): quarter ended 2022-09-30, filed 2022-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Performance is each holding's price change from its close on the 2022-09-30 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.
| Stock | Country of operation | Class | Shares | Value | % of listed | Quarter end | Filed | Performance |
|---|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics, Inc. | COM | 0 | $0 | NaN% | 2022-09-30 | 2022-11-14 | +49.85% |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||